Validation of an automated safety surveillance system with prospective, randomized trial data - Wikidata - awgldk - TriplyDB

Validation of an automated safety surveillance system with prospective, randomized trial data

Validation of an automated safety surveillance system with prospective, randomized trial data

http://www.wikidata.org/entity/Q33385061

about

pSCANNER: patient-centered Scalable National Network for Effectiveness Research iDASH: integrating data for analysis, anonymization, and sharing The data extraction and longitudinal trend analysis network study of distributed automated postmarket cardiovascular device safety surveillance Evaluation of an automated safety surveillance system using risk adjusted sequential probability ratio testing.An evaluation of a distributed medical device safety surveillance system: the DELTA network study Automated surveillance to detect postprocedure safety signals of approved cardiovascular devices.Registry-Based Prospective, Active Surveillance of Medical-Device Safety.

P2860

Q28656420-B44233E1-4D77-4668-8AF3-05896BB510B7 Q28732138-2BE6D26C-6AF6-4600-912C-278E42772001 Q30876776-2C316BC4-CE31-4589-AC61-7A71BEE19B98 Q34101009-6FF9FB54-CB33-467D-861C-2F71120FA327 Q34756859-42CE5C8B-0A69-4284-829F-F24396F92E3A Q37458616-59F98053-2B59-4046-BF0F-BB49DC359899 Q39000188-67DD29AE-E46B-4106-B5B2-6F4139986C92

P2860

Validation of an automated safety surveillance system with prospective, randomized trial data

http://www.wikidata.org/entity/Q33385061

description

2008 nî lūn-bûn

@nan

2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Validation of an automated saf ...... pective, randomized trial data

@ast

Validation of an automated saf ...... pective, randomized trial data

@en

type

label

Validation of an automated saf ...... pective, randomized trial data

@ast

Validation of an automated saf ...... pective, randomized trial data

@en

prefLabel

Validation of an automated saf ...... pective, randomized trial data

@ast

Validation of an automated saf ...... pective, randomized trial data

@en

P1433

Q33385061-8D4D9059-0C9E-438A-BDAB-8F3DE0EF055D

P1476

Q33385061-C3B470B9-B290-4FFC-9D8B-366BC1B82F66

P2093

Q33385061-055551EE-45C1-4FEA-8144-B55B9EA5BA4D

Q33385061-3B8621B8-129D-4934-8EC2-2696EDC9E900

Q33385061-92E58BD6-05DC-4E2C-BFFB-C52410F63743

Q33385061-E4551BBA-7641-43AA-8486-8E182DB1661E

P2860

Q33385061-04093748-09BB-4DA8-A015-7C6DFA272158

Q33385061-27D1EA8E-A41A-470B-94D8-81032B5C94DE

Q33385061-2AC23250-D0F5-4347-BA07-6B5A54305256

Q33385061-45B290C9-CFDA-4D87-80E9-F4A2F82C52F7

Q33385061-45F87D48-81F0-4BB9-AFC2-C8371EA3C966

Q33385061-51231A4D-3836-45E2-ACFE-EFD316A1F207

Q33385061-544B02D3-D4FD-41C1-9F00-1A6EF1D7992E

Q33385061-5619CF0A-4259-4C29-9B81-9DA021629D0F

Q33385061-6186EEEB-943A-40AB-8E51-22E88BF14C0F

Q33385061-828CE373-8B34-4FFA-AEE0-623BBBC2C371

P304

Q33385061-59663C73-4ECA-4F78-ACFE-0E2EB766FA65

P31

Q33385061-2B178D3B-AF7C-4851-BD6F-A4E63BDFE684

P356

Q33385061-71BDFE82-ED32-498D-8D09-E089DD27C25F

P433

Q33385061-557B29B0-711A-4965-A09D-F7665511807B

P478

Q33385061-DED6B2E4-A479-40EE-BB1E-B96D6CAD59E8

P50

Q33385061-0C696580-9D86-4265-9ACE-BF0163FBCD22

Q33385061-B86438C7-F480-4EA5-B863-90D17AC46416

P577

Q33385061-B48B2488-D525-4EF4-9EAB-9550E78A5761

P5875

Q33385061-5E8B32B0-3029-4E1A-B516-E4E846CAE37A

P698

Q33385061-D0969E07-4C3C-41A5-B777-F92B4E7E5730

P932

Q33385061-C886E877-0E89-48F1-9443-E8F238DCA7C3

P356

0272989X08327110

P1433

Medical Decision Making

P1476

Validation of an automated saf ...... pective, randomized trial data

@en

P2093

Christopher P Cannon

http://www.w3.org/2001/XMLSchema#string

David A Morrow

http://www.w3.org/2001/XMLSchema#string

Frederic S Resnic

http://www.w3.org/2001/XMLSchema#string

Marc S Sabatine

http://www.w3.org/2001/XMLSchema#string

P2860

Use of risk-adjusted CUSUM and RSPRT charts for monitoring in medical contexts

Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

The meaning and use of the area under a receiver operating characteristic (ROC) curve

Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial.

Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial.

Monitoring device safety in interventional cardiology.

Real-time estimates in early detection of SARS

Risk-adjusted sequential probability ratio test control chart methods for monitoring operator and institutional mortality rates in interventional cardiology.

Rare adverse event monitoring of medical devices with the use of an automated surveillance tool

A review of goodness of fit statistics for use in the development of logistic regression models.

P304

247-256

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0272989X08327110

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

Lucila Ohno-Machado

Michael E. Matheny

P577

2008-11-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23479541

http://www.w3.org/2001/XMLSchema#string

P698

19015285

http://www.w3.org/2001/XMLSchema#string

P932

2743924

http://www.w3.org/2001/XMLSchema#string